
Elaine Fields APRN, FNP-C, CARN-AP
Director of Addiction Services
Ashland, Kentucky
Medically reviewed by Dr. Jerrel Boyer, D.O. — Medical Director, Fresh Start Health Centers · Last reviewed: August 6, 2026
If you’re comparing Brixadi vs. Sublocade vs. Suboxone, you’re already asking the right question. All three are FDA-approved forms of buprenorphine — the most effective medication for opioid use disorder — and all three are available at Fresh Start Health across Eastern Kentucky. The real question isn’t which one is “best.” It’s which one fits your life. This guide gives you a clear, side-by-side comparison so you can walk into your first appointment ready to have a productive conversation with your provider.
| Feature | Suboxone | Sublocade | Brixadi |
|---|---|---|---|
| Active ingredient | Buprenorphine + naloxone | Buprenorphine | Buprenorphine |
| How it’s taken | Daily film or tablet, dissolves under the tongue | Once-monthly injection under the skin | Weekly OR monthly injection under the skin |
| Where you take it | At home | Fresh Start Health clinic | Fresh Start Health clinic |
| Dose flexibility | Highly adjustable, day to day | Fixed: 300 mg × 2 months, then 100 mg | Wide range: weekly 8–32 mg or monthly 64–128 mg |
| Time from decision to start | Same day | ~7 days of oral buprenorphine first | Often same day |
| Best suited for | People who want flexibility and control | People who are stable and want maximum convenience | People who want an injectable but also flexibility |
| Requires clinic visit? | No (after initial appointments) | Yes, monthly | Yes, weekly or monthly |
Use this table as a starting point — then read on to understand why each option fits different patients.
All three medications are built around buprenorphine, a partial opioid agonist that reduces cravings and prevents withdrawal without producing the same high as full opioids like heroin, fentanyl, or oxycodone. Buprenorphine has a built-in “ceiling effect” that makes it far safer in overdose than methadone or full opioid agonists. It’s the medication that SAMHSA recognizes as one of the most effective treatments for opioid use disorder, cutting overdose death risk by more than half compared to no medication.
All three are also part of medication-assisted treatment (MAT) — which means the medication works alongside counseling, medical follow-up, and community support. At Fresh Start Health, we prescribe all three across our Ashland, Grayson, Morehead, and Vanceburg clinics, and via telehealth for eligible Kentucky patients.
The difference between the three comes down to how the medication enters your body and how often you take it.
Suboxone is buprenorphine combined with naloxone in a small film or tablet that dissolves under your tongue once a day. It’s the most widely prescribed form of buprenorphine in the country and the option most patients start with.
Suboxone is FDA-approved for treatment of opioid use disorder. If you want the full picture on daily buprenorphine, see our Suboxone treatment page or read about how long people typically stay on Suboxone — a common question and one that deserves its own conversation.
Sublocade® is a long-acting buprenorphine injection administered by a healthcare provider once a month. After injection into the fatty tissue of the abdomen, the medication forms a small deposit under the skin that releases buprenorphine steadily over the following weeks.
Sublocade is FDA-approved for treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a transmucosal buprenorphine-containing product, followed by dose adjustment for a minimum of 7 days.
Brixadi® is also a long-acting buprenorphine injection, but it comes in both weekly and monthly formulations and a wider range of dose strengths (weekly: 8, 16, 24, or 32 mg; monthly: 64, 96, or 128 mg). This built-in flexibility means treatment can be started faster and tailored more precisely to each patient.
Brixadi is FDA-approved for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine-containing product or who are already being treated with buprenorphine.
This is the comparison most patients researching injectables want a clear answer on. Both are buprenorphine injections. Both are given by a provider. Both work extremely well for opioid use disorder. But they differ in ways that matter for real-world life.
Dosing schedule. Sublocade is monthly only. Brixadi comes in both weekly and monthly versions — so if you want to build up to a monthly injection gradually, Brixadi lets you start weekly and step up.
Time to first injection. Sublocade typically requires about 7 days of oral buprenorphine before you can get your first shot. Brixadi weekly can often be started after a single oral test dose — sometimes on the same day as your first appointment. If you’re eager to move to an injectable fast, Brixadi has the edge.
Dose range. Sublocade uses a fixed protocol: 300 mg × 2 months, then 100 mg monthly. Brixadi offers seven different dose options across weekly and monthly formulations, so your provider can fine-tune to what your body actually needs.
Injection site. Sublocade goes into the abdomen only. Brixadi can be injected into the buttock, thigh, upper arm, or abdomen — useful if you have skin sensitivity or scar tissue in one area.
Cost and coverage. In Kentucky, both are covered by Medicaid and most commercial plans when prescribed for opioid use disorder. As a 340B covered entity, Fresh Start Health can often help make either affordable regardless of your coverage.
Which one wins? Neither. They win for different patients. If you’re already stable on Suboxone and want “set-and-forget” convenience, Sublocade is often the cleaner choice. If you want an injectable but need to start fast, want dose flexibility, or aren’t yet sure you want to commit to monthly, Brixadi is usually the better fit.
There’s no universally “best” medication. There’s only the best fit for your situation. A rough framework:
The most important thing is this: any buprenorphine-based treatment dramatically reduces your risk of overdose and supports long-term recovery. Waiting for the “perfect” choice is riskier than starting with a good one. You and your Fresh Start Health provider will decide together based on your medical history, your daily life, and your goals — and you can switch between them later if your needs change.
Buprenorphine medications are generally well-tolerated, but every medication has side effects worth knowing about.
Common with all three:
Specific to the injectables (Sublocade and Brixadi):
When to call the clinic:
Fresh Start Health providers are available by phone during business hours and via our 24-hour on-call line for anything urgent.
Many patients start on Suboxone and later switch to an injectable — or switch between injectables — as their needs change. All of these transitions are routine.
Your Fresh Start Health provider will map out the timing to keep you comfortable throughout any transition. If you’re worried about withdrawal during a switch, that’s a conversation worth having up front.
Fresh Start Health accepts Kentucky Medicaid, Medicare, and most commercial insurance plans. All three medications — Suboxone, Sublocade, and Brixadi — are covered under most plans for opioid use disorder treatment.
As a 340B covered entity serving Eastern Kentucky, we’re able to access discounted medication pricing that we pass through to our patients. Even if you’re uninsured or underinsured, we work with every patient individually to find an affordable path to treatment. If cost is a concern, tell us at your first call — we’ll walk through your options before you commit to anything.
We provide Suboxone, Sublocade, and Brixadi treatment at all four Fresh Start Health clinics: Ashland, Grayson, Morehead, and Vanceburg — plus telehealth for eligible Kentucky patients. Same-week appointments are usually available, and our on-site team handles insurance verification so you can focus on getting started, not paperwork.
For more on the injectable options specifically, see our Sublocade and Brixadi treatment page.
All three contain buprenorphine, the medication that reduces opioid cravings and withdrawal. The difference is how they’re delivered. Suboxone is a daily film or tablet you take at home. Sublocade is a once-monthly injection given in the clinic. Brixadi is an injection available in both weekly and monthly forms with more dose options. The best choice depends on how much daily involvement you want and how quickly you want to start an injectable.
Neither is universally better — they suit different needs. Sublocade is monthly only and typically requires about 7 days of oral buprenorphine first, so it fits people who are already stable and want maximum convenience. Brixadi comes in weekly or monthly strengths and can be started with just a single oral dose first, so it fits people who want an injectable sooner or need more flexible dosing. A Fresh Start Health provider can help you decide based on your treatment plan.
Yes. Many people start on daily Suboxone and later switch to a long-acting injection once they’re stable. For Sublocade, most providers want you stabilized on oral buprenorphine for about 7 days before the first injection. Brixadi can often be started with just a single oral test dose. Your Fresh Start Health provider will time the switch to keep you comfortable and avoid withdrawal symptoms.
Fresh Start Health accepts Kentucky Medicaid and most commercial insurance plans, and all three medications are covered under most plans for opioid use disorder treatment. As a 340B covered entity serving Eastern Kentucky, we work to keep treatment affordable regardless of your coverage. If cost is a concern, call us at 606-225-8200 or use our chat function and we’ll help you understand your options before you start.
For most Kentucky Medicaid patients, Brixadi is covered with little to no out-of-pocket cost when prescribed for opioid use disorder. Commercial insurance coverage varies by plan — most cover Brixadi with a specialty medication copay. Fresh Start Health’s 340B status often allows us to reduce costs further. Coverage verification is included as part of your first appointment, so you’ll know your exact cost before your first injection.
Buprenorphine from a Sublocade injection releases steadily over the month following your shot. Even after you stop injections, the depot under the skin can continue releasing medication for 12 months or longer, with buprenorphine detectable in bloodwork for several months. That’s why your provider carefully plans any transition off Sublocade — the medication doesn’t clear quickly like a daily pill.
Alcohol is generally not recommended with buprenorphine because both are central nervous system depressants and combining them increases the risk of sedation, breathing problems, and overdose. Occasional light drinking may be safer than binge drinking, but we recommend talking with your provider about your specific situation. If alcohol use is part of what you’re working through, alcohol use disorder is also something we treat at Fresh Start Health.
Weekly Brixadi is often better for patients who are earlier in treatment, want more frequent check-ins with their clinic team, or aren’t yet ready for a long commitment to a single dose. Monthly Brixadi is often better for patients who are stable, want maximum convenience, and don’t want weekly clinic visits. Many patients start with weekly Brixadi and transition to monthly once they’ve found their stable dose.
Everything you share with us about opioid use, medication history, and treatment is protected under federal privacy law — including 42 CFR Part 2, which provides stronger confidentiality protections than standard HIPAA rules for addiction treatment records. Your employer, family, and insurance company cannot access your records without your explicit written consent.
Choosing between Suboxone, Sublocade, and Brixadi is a conversation, not a test. Our team at Fresh Start Health will walk you through each option and help you decide what fits your life.
Call us at 606-225-8200 or use our chat function on the site — we’re here to make the first step easy. If you’d rather send a message, contact us here and we’ll get back to you within one business day.
Dr. Jerrel Boyer, D.O. is the Medical Director of Fresh Start Health Centers, a multi-location clinic serving Eastern Kentucky. Board-certified in Neurosurgery, Dr. Boyer transitioned his clinical focus to addiction medicine and specialty care to address the opioid, hepatitis C, and HIV epidemics affecting rural Kentucky communities. He oversees medication-assisted treatment (MAT), hepatitis C cure therapy, PrEP for HIV prevention, and telehealth-delivered care across four locations — Ashland, Grayson, Morehead, and Vanceburg.
This content is for informational purposes only and is not a substitute for professional medical advice. Talk to a Fresh Start Health provider or your own clinician about which treatment is right for you. Individual outcomes vary; treatment is personalized to each patient.
5 providers

Director of Addiction Services
Ashland, Kentucky

Family Nurse Practitioner
Ashland, Kentucky

Family Nurse Practitioner
Grayson, Kentucky

Family Nurse Practitioner
Vanceburg, Kentucky

Family Nurse Practitioner
Morehead, Kentucky